United States
With decades of experience, Andy specializes in strategy, finance, and corporate development. He has collaborated with healthcare-centered organizations to shape innovative solutions that support and improve healthcare outcomes. At Mass General Brigham, he supported the commercialization of Insight, an enterprise research administration platform serving over 25,000 users in the largest U.S. academic medical research center. His expertise reflects a commitment to advancing healthcare through strategic initiatives and impactful technological solutions.
• Lead a global team focused on transforming migraine treatment through FDA-cleared neuromodulation devices. • Drive strategic growth and foster innovation in noninvasive therapeutics for drug-free migraine relief. • Expand access to novel health technologies, empowering patients to manage their migraines effectively. • Passionate about connecting individuals with effective solutions to improve quality of life.
Personalized support to help nurses thrive in healthcare
• Served as an advisor to MBB Innovations on the commercialization of Insight, enhancing enterprise research administration. • Collaborated with stakeholders to optimize and commercialize the platform utilized by over 25,000 end users and contributed to the strategic development of Insight.
Founded in 2018, PatchRx is dedicated to mitigating the adverse effects and costs of medication non-adherence by using patented smart pill bottle caps and a comprehensive software platform. Their system enables real-time tracking of patient medication-taking behaviors by integrating data from smart caps attached to prescription bottles, transmitting this information directly to care providers through the PatchRx web app or connected care management platforms.
Founded in 2014 and headquartered in Tel Aviv, Israel, Genoox provides cloud-based tools for genomic data interpretation in clinical and research settings. Its Franklin platform supports real-time, evidence-based analysis of hereditary variants, helping clinicians, researchers, and genetic professionals make informed decisions.